Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
247.53
+1.26 (0.51%)
May 15, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Employees
Bio-Rad Laboratories had 7,450 employees as of December 31, 2025. The number of employees decreased by 250 or -3.25% compared to the previous year.
Employees
7,450
Change (1Y)
-250
Growth (1Y)
-3.25%
Revenue / Employee
$347,638
Profits / Employee
$22,658
Market Cap
6.62B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7,450 | -250 | -3.25% |
| Dec 31, 2024 | 7,700 | -330 | -4.11% |
| Dec 31, 2023 | 8,030 | -170 | -2.07% |
| Dec 31, 2022 | 8,200 | 300 | 3.80% |
| Dec 31, 2021 | 7,900 | -100 | -1.25% |
| Dec 31, 2020 | 8,000 | -120 | -1.48% |
| Dec 31, 2019 | 8,120 | -140 | -1.69% |
| Dec 31, 2018 | 8,260 | 110 | 1.35% |
| Dec 31, 2017 | 8,150 | -100 | -1.21% |
| Dec 31, 2016 | 8,250 | 480 | 6.18% |
| Dec 31, 2015 | 7,770 | 170 | 2.24% |
| Dec 31, 2014 | 7,600 | -150 | -1.94% |
| Dec 31, 2013 | 7,750 | 370 | 5.01% |
| Dec 31, 2012 | 7,380 | 350 | 4.98% |
| Dec 31, 2011 | 7,030 | 150 | 2.18% |
| Dec 31, 2010 | 6,880 | 280 | 4.24% |
| Dec 31, 2009 | 6,600 | 0 | - |
| Dec 31, 2008 | 6,600 | 200 | 3.13% |
| Dec 31, 2007 | 6,400 | 1,000 | 18.52% |
| Dec 31, 2006 | 5,400 | 200 | 3.85% |
| Dec 31, 2005 | 5,200 | 0 | - |
| Dec 31, 2004 | 5,200 | 400 | 8.33% |
| Dec 31, 2003 | 4,800 | 200 | 4.35% |
| Dec 31, 2002 | 4,600 | 300 | 6.98% |
| Dec 31, 2001 | 4,300 | 500 | 13.16% |
| Dec 31, 2000 | 3,800 | -300 | -7.32% |
| Dec 31, 1999 | 4,100 | 1,425 | 53.27% |
| Dec 31, 1998 | 2,675 | 25 | 0.94% |
| Dec 31, 1997 | 2,650 | 115 | 4.54% |
| Dec 31, 1996 | 2,535 | 75 | 3.05% |
| Dec 31, 1995 | 2,460 | 130 | 5.58% |
| Dec 31, 1994 | 2,330 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Smith & Nephew | 16,988 |
| Bruker | 11,085 |
| Integer Holdings | 11,000 |
| Bio-Rad Laboratories | 7,450 |
| Globus Medical | 6,000 |
| Insulet | 5,400 |
| Penumbra | 4,700 |
| LivaNova | 3,300 |
BIO News
- 1 day ago - Bio-Rad resumed with an Outperform at RBC Capital - TheFly
- 7 days ago - Bio-Rad to Participate in Upcoming Investor Conferences - Business Wire
- 15 days ago - Bio-Rad price target lowered to $290 from $320 at Wells Fargo - TheFly
- 15 days ago - Bio-Rad Laboratories Earnings Call Transcript: Q1 2026 - Transcripts
- 15 days ago - Bio-Rad reports Q1 EPS $1.89, consensus $1.99 - TheFly
- 15 days ago - Bio-Rad Reports First-Quarter 2026 Financial Results - Business Wire
- 4 weeks ago - Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026 - Business Wire
- 5 weeks ago - Bio-Rad downgraded to Neutral from Buy at Citi - TheFly